Gerresheimer AG (ETR:GXI – Get Free Report)’s share price traded up 1.2% on Tuesday . The stock traded as high as €30.36 and last traded at €29.40. 532,016 shares were traded during mid-day trading, an increase of 278% from the average session volume of 140,925 shares. The stock had previously closed at €29.04.
Gerresheimer Stock Down 3.5%
The company has a debt-to-equity ratio of 87.94, a quick ratio of 0.40 and a current ratio of 0.80. The stock’s fifty day simple moving average is €37.87 and its two-hundred day simple moving average is €46.65. The company has a market capitalization of $971.64 million, a price-to-earnings ratio of 8.50, a P/E/G ratio of 0.82 and a beta of 0.94.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Read More
- Five stocks we like better than Gerresheimer
- Following Congress Stock Trades
- The Drone Arms Race: From Battlefield to Balance Sheet
- 3 Dividend Kings To Consider
- Why Wall Street Is Backing These 3 Comeback Stocks
- 3 REITs to Buy and Hold for the Long Term
- Intel’s Breakout Quarter: More Than a Beat, It’s a Declaration
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.
